Studies have shown that TP73-AS1 is significantly upregulated in various gastrointestinal tumors, including esophageal cancer (EC), HCC, GC, and CC, and it is closely associated with reduced patient survival rates, suggesting its potential as an auxiliary diagnostic biomarker for gastrointestinal tumors [74]. Here, TP73 is linked to digestive system neoplasm.